Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consolidation Intensity-Modulated Whole Abdominal Radiotherapy for High-Risk Patients With Ovarian Cancer Stage FIGO III

NCT01180504 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT01180504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01180504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consolidation Intensity-Modulated Whole Abdominal Radiotherapy for High-Risk Patients With Ovarian Cancer Stage FIGO III
Lead sponsor
University Hospital Heidelberg
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2010
Completion date
August 31, 2016
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, primary peritoneal carcinoma, tubal carcinoma